Fortress Biotech (FBIO) R&D In Process (2016 - 2023)
Fortress Biotech (FBIO) has 10 years of R&D In Process data on record, last reported at $7000.0 in Q4 2023.
- For Q4 2023, R&D In Process changed N/A year-over-year to $7000.0; the TTM value through Dec 2023 reached $4.3 million, changed N/A, while the annual FY2024 figure was $252000.0, 94.14% down from the prior year.
- R&D In Process reached $7000.0 in Q4 2023 per FBIO's latest filing, down from $60000.0 in the prior quarter.
- Across five years, R&D In Process topped out at $14.9 million in Q1 2020 and bottomed at -$14.1 million in Q4 2020.
- Average R&D In Process over 5 years is $1.5 million, with a median of $450000.0 recorded in 2019.
- Peak YoY movement for R&D In Process: soared 3203.78% in 2020, then plummeted 99.99% in 2022.
- A 5-year view of R&D In Process shows it stood at $450000.0 in 2019, then crashed by 3232.22% to -$14.1 million in 2020, then skyrocketed by 126.84% to $3.8 million in 2021, then tumbled by 98.76% to $47000.0 in 2022, then crashed by 85.11% to $7000.0 in 2023.
- Per Business Quant database, its latest 3 readings for R&D In Process were $7000.0 in Q4 2023, $60000.0 in Q3 2023, and $3000.0 in Q2 2023.